Abbott Wins Unrestricted Use Of Stent Patent

Law360, New York (August 8, 2007, 12:00 AM EDT) -- A federal judge has adopted Abbott Laboratories’s interpretation of its settlement of a coronary stent patent dispute with Medinol Ltd., finding that Abbott may exploit the patent however it pleases rather than just to manufacture a specific product.

Judge Shira A. Scheindlin of the U.S. District Court for the Southern District of New York on Tuesday granted Abbott’s motion to enforce the settlement and denied Medinol’s. Abbott had argued that the settlement’s licensing arrangement was unrestricted regarding the patent’s use, while Medinol said the deal was...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.